Please assess the completion status of the following clinical trial:

Trial Title: Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Indicated for IVF/ICSI in the context of assisted reproductive technology (ART)~* Follow a gonadotropin releasing hormone (GnRH) antagonist protocol, single injection of human chorionic gonadotropin (hCG) for triggering final follicular maturation and luteal support with vaginal micronized progesterone.~* Single fresh D5 embryo transfer~Exclusion Criteria:~* Frozen-thawed embryo transfer~* Donor egg in the current transfer~* More than 20 oocytes in the current controlled ovarian hyperstimulation (COH) cycle~* Serum P4 greater than 1.5 ng/mL prior to hCG administration

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- Nolasiban 900 mg (Type: EXPERIMENTAL): Nolasiban dispersible tablets for single oral administration
- Placebo (Type: PLACEBO_COMPARATOR): Placebo dispersible tablets for single oral administration

Based on this trial design, predict the completion outcome and termination type (if applicable).